|
AM1009a-ev
|
Abcepta, Inc.
|
GFP Tag [168AT1211], Mouse Monoclonal Antibody
|
Human
|
WB, IF
|
|
|
AM1009a
|
Abcepta, Inc.
|
GFP Tag [168AT1211], Mouse Monoclonal Antibody
|
Human
|
WB, IF
|
|
|
ATGP1802-250ug
|
NKMax Bio (ATGen)
|
MRPL28 [56-256 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP1802-50ug
|
NKMax Bio (ATGen)
|
MRPL28 [56-256 a.a.], Recombinant Protein
|
Human
|
SDS-PAGE
|
|
|
ATGP0304-100ug
|
NKMax Bio (ATGen)
|
Protein A [37-469 a.a.], Recombinant Protein
|
S.aureus
|
SDS-PAGE
|
|
|
ATGP0304-500ug
|
NKMax Bio (ATGen)
|
Protein A [37-469 a.a.], Recombinant Protein
|
S.aureus
|
SDS-PAGE
|
|
|
GTX28158
|
GeneTex International Corporation
|
CD34 [MEC14.7], Rat Monoclonal Antibody
|
Human, Mouse, Rabbit
|
ELISA, FACS, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WB
|
|
|
HY-103174-10mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103174-5mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103187-1mg
|
MedChemexpress LLC
|
HEMADO [CAS 403842-38-6]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-105268-10mg
|
MedChemexpress LLC
|
AzddMeC [CAS 87190-79-2]
|
|
COVID-19-anti-virus
|
|
|
HY-105268-100mg
|
MedChemexpress LLC
|
AzddMeC [CAS 87190-79-2]
|
|
COVID-19-anti-virus
|
|
|
HY-105268-25mg
|
MedChemexpress LLC
|
AzddMeC [CAS 87190-79-2]
|
|
COVID-19-anti-virus
|
|
|
HY-105268-5mg
|
MedChemexpress LLC
|
AzddMeC [CAS 87190-79-2]
|
|
COVID-19-anti-virus
|
|
|
HY-105268-50mg
|
MedChemexpress LLC
|
AzddMeC [CAS 87190-79-2]
|
|
COVID-19-anti-virus
|
|
|
HY-106850-10mg
|
MedChemexpress LLC
|
3′-Azido-2′,3′-dideoxyuridine [CAS 84472-85-5]
|
|
COVID-19-anti-virus
|
|
|
HY-106850-100mg
|
MedChemexpress LLC
|
3′-Azido-2′,3′-dideoxyuridine [CAS 84472-85-5]
|
|
COVID-19-anti-virus
|
|
|
HY-106850-25mg
|
MedChemexpress LLC
|
3′-Azido-2′,3′-dideoxyuridine [CAS 84472-85-5]
|
|
COVID-19-anti-virus
|
|
|
HY-106850-5mg
|
MedChemexpress LLC
|
3′-Azido-2′,3′-dideoxyuridine [CAS 84472-85-5]
|
|
COVID-19-anti-virus
|
|
|
HY-106850-50mg
|
MedChemexpress LLC
|
3′-Azido-2′,3′-dideoxyuridine [CAS 84472-85-5]
|
|
COVID-19-anti-virus
|
|
|
HY-114312-10mg
|
MedChemexpress LLC
|
MD-224 [CAS 2136247-12-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114312-100mg
|
MedChemexpress LLC
|
MD-224 [CAS 2136247-12-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114312-25mg
|
MedChemexpress LLC
|
MD-224 [CAS 2136247-12-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114312-5mg
|
MedChemexpress LLC
|
MD-224 [CAS 2136247-12-4]
|
|
Cancer-programmed cell death
|
|
|
HY-114312-50mg
|
MedChemexpress LLC
|
MD-224 [CAS 2136247-12-4]
|
|
Cancer-programmed cell death
|
|
